177 related articles for article (PubMed ID: 21720514)
21. Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.
Chen BA; Dai YY; Wang XM; Zhang RY; Xu WL; Shen HL; Gao F; Sun Q; Deng XJ; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Chen NN
Int J Nanomedicine; 2008; 3(3):343-50. PubMed ID: 18990943
[TBL] [Abstract][Full Text] [Related]
22. Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells.
Chen B; Sun Q; Wang X; Gao F; Dai Y; Yin Y; Ding J; Gao C; Cheng J; Li J; Sun X; Chen N; Xu W; Shen H; Liu D
Int J Nanomedicine; 2008; 3(2):277-86. PubMed ID: 18686787
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
24. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
[TBL] [Abstract][Full Text] [Related]
25. [Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line].
Li J; Chen BA; Zhu MS; Gao F; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Song HH; Ma Y; Bao W; Sun XC; Cheng HY; Xu WL; Shen HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):65-9. PubMed ID: 18315902
[TBL] [Abstract][Full Text] [Related]
26. Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo.
Chen BA; Lai BB; Cheng J; Xia GH; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Xu CR; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
Int J Nanomedicine; 2009; 4():201-8. PubMed ID: 19918366
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance.
Ren Y; Zhang H; Chen B; Cheng J; Cai X; Liu R; Xia G; Wu W; Wang S; Ding J; Gao C; Wang J; Bao W; Wang L; Tian L; Song H; Wang X
Int J Nanomedicine; 2012; 7():2261-9. PubMed ID: 22619560
[TBL] [Abstract][Full Text] [Related]
28. [Study on the relationship between [Ca2+]i and the MDR formation in K562/A02 cells].
Chen BA; Zhou Y; Cheng J; Dong Y; Qian XJ; Sheng M; Wang T; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):159-62. PubMed ID: 15157324
[TBL] [Abstract][Full Text] [Related]
29. [Reversal effect of tetrandrine in combination with droloxifene on cell line K562/A02 and its correlation with inducted apoptosis].
Zhou Y; Chen BA; Dong Y; Zhang P; Cheng J; Sheng M; Wang T; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):321-3. PubMed ID: 15228658
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
[TBL] [Abstract][Full Text] [Related]
31. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy.
Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564
[TBL] [Abstract][Full Text] [Related]
32. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
[TBL] [Abstract][Full Text] [Related]
33. [Study of mifepristone on reversing multidrug resistance of leukemic cell line K562/A02].
Kong DX; Chen CY; Xu FY; Jia JH
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):555-9. PubMed ID: 18078134
[TBL] [Abstract][Full Text] [Related]
34. Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
Bao W; Liu R; Xia G; Wang F; Chen B
Drug Des Devel Ther; 2019; 13():1107-1115. PubMed ID: 31040647
[TBL] [Abstract][Full Text] [Related]
35. Effect of interaction of magnetic nanoparticles of Fe₃O₄ and artesunate on apoptosis of K562 cells.
Wang Y; Han Y; Yang Y; Yang J; Guo X; Zhang J; Pan L; Xia G; Chen B
Int J Nanomedicine; 2011; 6():1185-92. PubMed ID: 21822380
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
Wu W; Chen B; Cheng J; Wang J; Xu W; Liu L; Xia G; Wei H; Wang X; Yang M; Yang L; Zhang Y; Xu C; Li J
Int J Nanomedicine; 2010 Dec; 5():1079-84. PubMed ID: 21170355
[TBL] [Abstract][Full Text] [Related]
37. [Study on reversal effect of nilotinib in combination with 5-BrTet on multidrug resistance of K562/A02 cell line].
Chen BA; Shan XY; Chen J; Wang F; Ding JH; Gao C; Zhao G; Wang XM; Xu WL; Gao F; Xia GH; Schmitt M
Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):385-8. PubMed ID: 21122353
[TBL] [Abstract][Full Text] [Related]
38. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
[TBL] [Abstract][Full Text] [Related]
39. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells.
Chen B; Liang Y; Wu W; Cheng J; Xia G; Gao F; Ding J; Gao C; Shao Z; Li G; Chen W; Xu W; Sun X; Liu L; Li X; Wang X
Int J Nanomedicine; 2009; 4():251-9. PubMed ID: 20011242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
